4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-19-053661
Director acquired 218,400 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Frueh Klaus · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-10-16 | Conversion : show line 1 in the form | +218,400 | 362,844 | I |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-10-16 | Conversion : show line 2 in the form Series A-2 Convertible Preferred Stock | −218,400 | 0 | I |
Loading xslF345X03/doc4.xml…